BRAIN.Q

Restorative Brain Health Therapeutics to Reverse Disability After Neurological Disease

Health Tech & Life Sciences

Private

Company Overview

Snapshot

Founded in August 2016 by Yotam Drechsler, Prof. Esther Shohami, and Yaron Segal, BRAIN.Q operates with 11–50 employees. The company has raised a total of $52.4M across 4 funding rounds from 11 investors.

Business overview

BRAIN.Q is dedicated to transforming neurological recovery through non-invasive therapies. The company leverages advanced AI-powered technology to develop network-targeting electromagnetic precision therapy, specifically designed to enhance and accelerate brain recovery following ischemic stroke. This therapy is delivered via a cloud-based platform, making it adaptable for both hospital and home use. BRAIN.Q operates within the Health Tech & Life Sciences sector, focusing on digital healthcare, digital therapeutics, and medical technologies, serving patients and providers globally.

Strategic signal

In June 2024, BRAIN.Q was recognized as a Tech Pioneer by the World Economic Forum for its innovative brain health platform aimed at treating stroke disability. This recognition highlights the company's significant advancements in neurological recovery and signals strong validation of its AI-powered electromagnetic precision therapy within the global health technology landscape, potentially accelerating its market adoption and strategic partnerships.

Company Intelligence Q&A

What is BRAIN.Q's core mission?: BRAIN.Q's mission is to transform lives by developing innovative, noninvasive therapies for restorative brain health, aiming to reverse disability after neurological diseases, particularly ischemic stroke.
When was BRAIN.Q founded and by whom?: BRAIN.Q was founded in August 2016 by Yotam Drechsler, Prof. Esther Shohami, and Yaron Segal.
What significant recognition did BRAIN.Q receive in June 2024?: In June 2024, BRAIN.Q was recognized as a Tech Pioneer by the World Economic Forum for its innovative brain health platform designed to treat stroke disability.
Which investors participated in BRAIN.Q's August 2021 funding round?: In August 2021, BRAIN.Q received funding from investors including lead investors Hanaco Ventures and OurCrowd.
What is the primary focus of BRAIN.Q's technology?: BRAIN.Q's primary focus is on developing AI-powered, network-targeting electromagnetic precision therapy to enhance and accelerate brain recovery following ischemic stroke, delivered through a cloud-based platform.

External links

BRAIN.Q — full profile (machine-readable)

BRAIN.Q is redefining the future of neurological recovery, with a mission to transform lives through innovative, noninvasive therapies. The company utilizes advanced AI-powered technology to develop network-targeting electromagnetic precision therapy, designed to enhance and accelerate brain recovery following ischemic stroke—the leading cause of disability worldwide. Delivered through a cloud-based platform, the therapy is seamlessly adaptable for both hospital and home settings. Celebrated as a pioneer in neurological innovation, BRAIN.Q has earned CE Mark approval, the FDA’s Breakthrough Device Designation, and the esteemed recognition of the European Innovation Council. Building on these advancements, BRAIN.Q is actively progressing its pivotal EMAGINE II study in the U.S., aiming to secure FDA clearance for its Q Therapeutic System and expand its transformative impact on patient recovery. Guided by a world-class leadership team and a bold vision for the future of neurological recovery, BRAIN.Q is driven by its mission to restore brain health and dignity to stroke survivors, empowering them to regain independence.

Facts
Name	BRAIN.Q
One-liner	Restorative Brain Health Therapeutics to Reverse Disability After Neurological Disease
Type	Startup
Primary sector	Health Tech & Life Sciences
Founded	2016
Employees	11-50
Employees (exact)	35
HQ / location	Jerusalem, Givat Ram, Jerusalem, Israel, Jerusalem District
Product stage	Clinical Trial
Website	https://brainqtech.com
LinkedIn	https://www.linkedin.com/company/5549321
Crunchbase	brainq
IL Registrar	514654904

Facts

Name

BRAIN.Q

One-liner

Restorative Brain Health Therapeutics to Reverse Disability After Neurological Disease

Type

Startup

Primary sector

Health Tech & Life Sciences

Founded

2016

Employees

11-50

Employees (exact)

HQ / location

Jerusalem, Givat Ram, Jerusalem, Israel, Jerusalem District

Product stage

Clinical Trial

Website

https://brainqtech.com

https://www.linkedin.com/company/5549321

Crunchbase

brainq

IL Registrar

514654904

Classification
Sectors	Health Tech & Life Sciences, Digital Healthcare, Digital Therapeutics
Core technology	Artificial Intelligence, Machine Learning
Target customers	Healthcare & Life Sciences, Healthcare, Patients, Providers
Business models	B2B2C, B2B
Tags	non-invasive, stroke, degenerative-diseases, medical-devices, neurology, rehabilitation, artificial-intelligence, machine-learning, digital-healthcare, clinics, hospitals, medical-technologies, neuroscience, digital-therapeutics, patients, wearable, mhealth

Classification

Sectors

Health Tech & Life Sciences, Digital Healthcare, Digital Therapeutics

Core technology

Artificial Intelligence, Machine Learning

Target customers

Healthcare & Life Sciences, Healthcare, Patients, Providers

Business models

B2B2C, B2B

Date	Round	Amount	Investors
May 2018	A Round	$7.3M	Qure Ventures, Natura Investments, IT-Farm, OurCrowd
May 2017	Seed	$3.5M	OurCrowd, Undisclosed Investor(s)
Jun 2018	nonequity	$2.6M	Horizon 2020 accelerator (lead)
Aug 2021	B Round	$39M	Hanaco Ventures (lead), OurCrowd (lead), IT-Farm, Dexcel Pharma, RunYoung Technology Transfer Center, Sailing Capital, Millhouse Capital, Qure Ventures, Peregrine Ventures

Name	Role	Founder
Kevin Sheth	Advisory Board
Jorgen Hansen	Advisory Board
Jeffrey L.	Advisory Board
Prof. Takao	Advisory Board
Steven C.	Advisory Board
Steven C.	Advisory Board
Prof. Takao	Advisory Board
Stacey Pugh	Board Member
Yotam Drechsler	Co-founder & CEO	yes
Prof. Esther Shohami	Co-founder & CSO	yes
Yaron Segal	Co-founder & Chief Innovation Officer	yes
Amir Salhuv	Chief Technology Officer
Assaf Lifshitz	VP Operations & Marketing
Liat Reiffman Laufer	HR Administrator
Moshe Coleman

Date	Source	Summary
Sep 23, 2024	www.medstarhealth.org	Research Examines Electromagnetic Device to Improve Stroke Recovery
Sep 5, 2024	www.israel21c.org	BRAIN.Q's helmet's tailored, low-intensity, low frequency electromagnetic stimulation aims to enhance and accelerate the brain's recovery after stroke.
Aug 1, 2024	www.mddionline.com	BRAIN.Q is Advancing Stroke Care Through Innovative Technologies
Jun 6, 2024	www.linkedin.com	BRAIN.Q Recognized as a Tech Pioneer by WEF 2024 for Its Innovative Brain Health Platform to Treat Stroke Disability
Dec 9, 2021	www.prnewswire.com	First Patient Enrolled in BrainQ's Pivotal Trial, EMAGINE™, for Frequency-Tuned Electromagnetic Field Therapy to Reduce Disability Following Ischemic Stroke
Aug 16, 2021	techcrunch.com	BrainQ raises $40M to transform stroke patient rehabilitation with its home therapy device
Mar 13, 2021	www.jpost.com	https://www.jpost.com/health-science/israeli-startup-develops-artificial-brainwaves-to-treat-strokes-661881
Feb 15, 2021	www.jpost.com	https://www.jpost.com/health-science/israeli-stroke-therapy-granted-fda-breakthrough-device-status-658988
Feb 11, 2021	www.prnewswire.com	BrainQ gets FDA Breakthrough status for its device for reducing disability following stroke
Jan 14, 2021	www.eurekalert.org	Electromagnetic stimulation may improve arm and hand function after spinal cord injury
Apr 2, 2020	medtech.pharmaintelligence.informa.com	Start-Up Spotlight: BrainQ Forsees New Era For Neurodisorder Treatment
Feb 7, 2019	www.jpost.com	https://www.jpost.com/Jpost-Tech/Business-and-Innovation/Hillels-Tech-Corner-Using-your-brain-580061?fbclid=IwAR1fCrQfRmU2rlNbnBwaslxr3PjewILnWEwhY8U55DXZm7x7Izo2p5BCnFo
May 15, 2018	techcrunch.com	BrainQ raises $5.3M to treat neurological disorders with the help of AI
Feb 28, 2018	futurism.com	A company wants to put a chip in your brain to cure disease
Feb 27, 2018	techcrunch.com	BrainQ aims to cure stroke and spinal cord injuries through mind-reader tech
Nov 2, 2017	www.haaretz.com	Israeli startup BrainQ tapped for Google AI program

BRAIN.Q

Company Overview

Snapshot

Business overview

Strategic signal

Company Intelligence Q&A

External links

Generate Slim Page